TCG Crossover Management’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

TCG Crossover Management’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,113,600	Closed	-$52.9M	–	30
2023 Q2	$52.9M	Hold	3,113,600	–	–	8.68%	4
2023 Q1	$26.5M	Buy	3,113,600 +780,300	+33%	+$6.43M	5.16%	9
2022 Q4	$20.2M	Buy	+2,333,300	New	+$18.8M	3.57%	11

Other funds holding VECT

RCM

Regency Capital Management Honolulu, Hawaii $251M AUM 32.13% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

TCG Crossover Management's VECT Position: Q3 2023 in Review

TCG Crossover Management sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 3,113,600 shares — an estimated $52.9M sold.

TCG Crossover Management first reported a position in VECT in Q4 2022 and held it in 3 quarters. The position peaked at $52.9M in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

TCG Crossover Management reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
TCG Crossover Management sold 3,113,600 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $52.9M.
TCG Crossover Management first reported a position in VectivBio Holding AG Ordinary Shares in Q4 2022 and held it in 3 quarters.
TCG Crossover Management's VectivBio Holding AG Ordinary Shares position peaked at $52.9M in Q2 2023.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on TCG Crossover Management's 13F filing for Q3 2023, filed 14 Nov 2023.